Charlotte's Web (CWEB) Competitors

HLS Therapeutics (TSE:HLS) and Charlotte's Web (TSE:CWEB) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, institutional ownership, earnings, risk, dividends, valuation, analyst recommendations, community ranking and media sentiment.

Is HLS or CWEB more profitable?

HLS Therapeutics has a net margin of -40.90% compared to Charlotte's Web's net margin of -81.43%. HLS Therapeutics' return on equity of -24.82% beat Charlotte's Web's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
HLS Therapeutics	-40.90%	-24.82%	-2.89%
Charlotte's Web	-81.43%	-77.80%	-17.25%

Does the media refer more to HLS or CWEB?

In the previous week, HLS Therapeutics and HLS Therapeutics both had 1 articles in the media. HLS Therapeutics' average media sentiment score of 0.00 equaled Charlotte's Web'saverage media sentiment score.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
HLS Therapeutics	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Charlotte's Web	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Do institutionals & insiders have more ownership in HLS or CWEB?

65.2% of HLS Therapeutics shares are owned by institutional investors. Comparatively, 3.3% of Charlotte's Web shares are owned by institutional investors. 0.4% of HLS Therapeutics shares are owned by company insiders. Comparatively, 11.3% of Charlotte's Web shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Do analysts recommend HLS or CWEB?

HLS Therapeutics currently has a consensus target price of C$3.63, suggesting a potential upside of 11.54%. Given HLS Therapeutics' higher probable upside, equities analysts plainly believe HLS Therapeutics is more favorable than Charlotte's Web.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
HLS Therapeutics	0 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.33
Charlotte's Web	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A

Does the MarketBeat Community believe in HLS or CWEB?

HLS Therapeutics received 34 more outperform votes than Charlotte's Web when rated by MarketBeat users. Likewise, 66.67% of users gave HLS Therapeutics an outperform vote while only 0.00% of users gave Charlotte's Web an outperform vote.

Company	Underperform	Outperform
HLS Therapeutics	Outperform Votes 34 66.67%	Underperform Votes 17 33.33%
Charlotte's Web	Outperform Votes No Votes	Underperform Votes 2 100.00%

Which has more volatility & risk, HLS or CWEB?

HLS Therapeutics has a beta of 1.07, suggesting that its share price is 7% more volatile than the S&P 500. Comparatively, Charlotte's Web has a beta of 1.91, suggesting that its share price is 91% more volatile than the S&P 500.

Which has better valuation & earnings, HLS or CWEB?

HLS Therapeutics has higher revenue and earnings than Charlotte's Web. HLS Therapeutics is trading at a lower price-to-earnings ratio than Charlotte's Web, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
HLS Therapeutics	C$58.89M	1.75	-C$24.09M	-C$1.01	-3.22
Charlotte's Web	C$54.55M	0.58	-C$44.42M	-C$0.40	-0.50

Summary

HLS Therapeutics beats Charlotte's Web on 11 of the 15 factors compared between the two stocks.